| Code | Description | Claims | Bene. Records | Total Paid |
|---|
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,681 |
1,388 |
$45K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,039 |
916 |
$31K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
843 |
740 |
$31K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
641 |
495 |
$28K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,132 |
994 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,726 |
1,456 |
$16K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
392 |
343 |
$16K |
| 87807 |
|
288 |
245 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
106 |
76 |
$864.90 |
| 94762 |
|
62 |
59 |
$699.66 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
75 |
53 |
$20.35 |
| 1111F |
|
111 |
105 |
$0.00 |
| 2010F |
|
136 |
129 |
$0.00 |
| S9083 |
Global fee urgent care centers |
45 |
31 |
$0.00 |